• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall VITEK 2 60 computer system

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
  Class 2 Device Recall VITEK 2 60 computer system see related information
Date Initiated by Firm February 18, 2013
Date Posting Updated March 25, 2013
Recall Status1 Terminated 3 on August 14, 2014
Recall Number Z-0989-2013
Recall Event ID 64394
Product Classification Susceptibility test cards, antimicrobial - Product Code LTW
Product VITEK 2 60 computer system when equipped with the following Hewlett-Packard PC models:

(1) rp5700, Cat. #W0452;
(2) rp5700 (refurbished), Cat. #W0452R;
(3) rp5800 XPE, Cat. 413642;
(4) rp5800 WES7, Cat. #413862;
(5) dc7100 8-port, Cat. #W0441;
(6) dc7100 8-port (refurbished), Cat. #W0441R;
(7) dc7700 8-port, Cat. #W0447;
(8) dc7700 8-port (refurbished), Cat. #W0447R;
(9) dc7800, Cat. #W0449; and
(10) dc7800 (refurbished), Cat. #W0449R.

VITEK 2 is an automated system designed for the identification and antimicrobial susceptibility testing of bacteria and yeast.
Code Information Manufactured from September, 2004, to present.
Recalling Firm/
Biomerieux Inc
595 Anglum Rd
Hazelwood MO 63042-2320
For Additional Information Contact Jeffrey S. Scanlan
Manufacturer Reason
for Recall
There is a potential to link an isolate result to the wrong patient and then upload the results to the LIS.
FDA Determined
Cause 2
Software design
Action bioMerieux sent an "URGENT PRODUCT CORRECTION NOTICE" dated February 20, 2013 to all affected customers. The letter identified the product, problem, and actions to be taken by the customers. Contact Emails were issued by the recalling firm on 2/18/2013 and 2/19/2013 to their subsidiaries and to distributors. Letters began issuing to customers via e-mail on 2/20/2013. Contact bioMerieux Clinical Customer Service at (800) 682-2666 for questions regarding this notice.
Quantity in Commerce For all 3 computers types: 16,736 originally distributed; 554 refurbished and redistributed
Distribution Worldwide Distribution-USA (nationwide) and the countries of Algeria, Angola, Argentina, Australia, Austria, Azerbaidjian, Bahrain, Belarus, Belgium, Benin, Bolivia, Bosnia, Brazil, Bulgaria, Burkina Faso, Camaroun, Canada, Chad, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Democratic Republic of Congo, Demark, Dominican Republic, Dutch Antilles, Ecuador, Egypt, El Salvador, Ethiopia, Finland, France, Gabon, Georgia, Germany, Greece, Guatemala, Guinea, Herzegovina, Honduras, Hungary, India, Indonesia, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Kosovo, Kuwait, Latvia, Lebanon, Libya, Lithuania, Macedonia, Malaysia, Mali, Mexico, Moldavia, Mongolia, Morocco, Myanmar, Netherlands, Netherlands, Nicaragua, Niger Niamey, Nigeria, Norway, Oman, Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Tunisia, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Venezuela, Vietnam, and Yemen.
Total Product Life Cycle TPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.